FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

403639006: Syringosquamous metaplasia due to cytotoxic therapy (disorder)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1771565016 Syringosquamous metaplasia due to cytotoxic therapy (disorder) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1782655010 Syringosquamous metaplasia due to cytotoxic therapy en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
7470831000241117 métaplasie syringosquameuse causée par un traitement cytotoxique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Is a Dermatosis due to cytotoxic therapy (disorder) true Inferred relationship Some
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Finding site Skin structure true Inferred relationship Some 1
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Causative agent (attribute) Pharmaceutical / biologic product (product) false Inferred relationship Some
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Associated morphology Morphologically abnormal structure false Inferred relationship Some 1
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Causative agent (attribute) Drug, medicament or biological substance false Inferred relationship Some
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Causative agent (attribute) A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. false Inferred relationship Some
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Causative agent (attribute) A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. false Inferred relationship Some
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Causative agent (attribute) Antineoplastic agent (substance) false Inferred relationship Some
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Associated morphology Morphologically abnormal structure false Inferred relationship Some 1
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Finding site Skin structure false Inferred relationship Some 2
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Causative agent (attribute) Cytotoxic true Inferred relationship Some 1
Syringosquamous metaplasia due to cytotoxic therapy (disorder) Due to The treatment of disease using chemical agents or drugs that are selectively toxic to the causative agent of the disease, such as a virus, bacterium, or other microorganism. true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

US English

Back to Start